Autoimmunity Highlights
SJR1.413
IT
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2024 | — | — | 1.413 | Q1 | 91.4% | |
| 2023 | — | — | 0.910 | Q2 | 83.2% | |
| 2022 | — | — | 0.931 | Q2 | 84.6% | |
| 2021 | — | — | 0.541 | Q3 | 69.6% | |
| 2020 | — | — | 0.814 | Q3 | 80.2% | |
| 2019 | — | — | 1.009 | Q2 | 85.8% | |
| 2018 | — | — | 0.891 | Q2 | 81.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2038-3274
ISSN
2038-0305
country
coverage
2010-2021